4//SEC Filing
BOUDREAUX GAIL 4
Accession 0001156039-24-000026
CIK 0001156039other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:21 PM ET
Size
11.3 KB
Accession
0001156039-24-000026
Insider Transaction Report
Form 4
BOUDREAUX GAIL
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2024-03-01$499.11/sh−19,256$9,610,862→ 117,777 total - Award
Common Stock
2024-03-01+8,415→ 126,192 total - Award
Common Stock
2024-03-01+34,517→ 160,709 total - Award
Employee Stock Option (Right to Buy)
2024-03-01+32,480→ 32,480 totalExercise: $499.11Exp: 2034-03-01→ Common Stock (32,480 underlying)
Holdings
- 60(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- [F2]Represents restricted share units. Restrictions lapse as follows: 2,805 shares each on 3/1/2025, 3/1/2026, and 3/1/2027.
- [F3]Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
- [F4]Balance includes 392.27 shares acquired on 3/24/2023, 389.71 shares acquired on 6/23/2023 and 388.21 shares acquired on 9/23/2023 through a dividend reinvestment plan.
- [F5]The option represents a right to purchase a total of 32,480 shares, and is exercisable in one installment of 10,826 shares and two installments of 10,827 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.
Documents
Issuer
Elevance Health, Inc.
CIK 0001156039
Entity typeother
Related Parties
1- filerCIK 0001287920
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:21 PM ET
- Size
- 11.3 KB